BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 158955)

  • 1. Fluorogenic peptide substrates for proteases in blood coagulation, kallikrein-kinin and fibrinolysis systems.
    Iwanaga S; Morita T; Kato H; Harada T; Adachi N; Sugo T; Maruyama I; Takada K; Kimura T; Sakakibara S
    Adv Exp Med Biol; 1979; 120A():147-63. PubMed ID: 158955
    [No Abstract]   [Full Text] [Related]  

  • 2. Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems.
    Friberger P
    Scand J Clin Lab Invest Suppl; 1982; 162():1-298. PubMed ID: 6221396
    [No Abstract]   [Full Text] [Related]  

  • 3. The kinin system: its relation to blood coagulation, fibrinolysis and the formed elements of the blood.
    Movat HZ
    Rev Physiol Biochem Pharmacol; 1978; 84():143-202. PubMed ID: 152965
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of andekalin and kontrikal on the blood proteolytic systems, vascular reactivity and the content of kinin system components].
    Kiselev VI; Panchenko AL; Shakhmatov II; Sharapova PKh; Kulikov VP
    Gematol Transfuziol; 1985 Aug; 30(8):32-6. PubMed ID: 2414149
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma protease and kinin release with special reference to plasmin.
    Hamberg U
    Ann N Y Acad Sci; 1968 Jun; 146(2):517-26. PubMed ID: 4240400
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies of blood coagulation-fibrinolysis regarding kallikrein-kinin system in severe preeclampsia.
    Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
    Agents Actions Suppl; 1992; 38 ( Pt 2)():342-9. PubMed ID: 1462840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood coagulation, fibrinolysis, kallikrein-kinin system and treatment of their disorders].
    Ogata H
    Masui; 1975 May; 24(5):479-85. PubMed ID: 1172022
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytotoxicity and effects of T2-toxin on plasma proteins involved in coagulation, fibrinolysis and kallikrein-kinin system.
    Johnsen H; Odden E; Johnsen BA; Bøyum A; Amundsen E
    Arch Toxicol; 1988 Jan; 61(3):237-40. PubMed ID: 3281632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kallikrein-kinin, fibrinolytic and coagulation systems of the blood of patients with salmonellosis treated with indomethacin].
    Pak SG; Bol'shakova TD; Kuznetsov VA; Mamaeva LV
    Klin Med (Mosk); 1984 Oct; 62(10):99-102. PubMed ID: 6569264
    [No Abstract]   [Full Text] [Related]  

  • 10. [State of the kallikrein-kinin, blood coagulation and fibrinolytic systems of blood in various forms of influenza].
    Starshov PD; Egorova MI; Beziaeva LA
    Ter Arkh; 1980; 52(3):125-8. PubMed ID: 6901362
    [No Abstract]   [Full Text] [Related]  

  • 11. Formation of human plasma kinin.
    Colman RW
    N Engl J Med; 1974 Sep; 291(10):509-15. PubMed ID: 4604486
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of endotoxin and proteases in multiple organ failure (MOF).
    Aasen AO; Rishovd AL; Stadaas JO
    Prog Clin Biol Res; 1989; 308():315-22. PubMed ID: 2675056
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biochemistry of the kallikrein-kinin system].
    Kato H; Fujii S
    Nihon Rinsho; 1978 Aug; 36(8):2865-72. PubMed ID: 152362
    [No Abstract]   [Full Text] [Related]  

  • 14. [The kallikrein-kinin, coagulation and fibrinolytic systems of the blood in patients with chronic glomerulonephritis and the hypertension syndrome].
    Nazar PS; Cherniavskaia GF
    Vrach Delo; 1989 Aug; (8):6-8. PubMed ID: 2588532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kallikrein-kinin, coagulative and fibrinolytic blood systems in patients with hemorrhagic fever and renal syndrome].
    Sirotin BZ; Obukhova GG; Mogila TV
    Ter Arkh; 1981; 53(9):84-7. PubMed ID: 6117951
    [No Abstract]   [Full Text] [Related]  

  • 16. [Function of the blood kallikrein-kinin, coagulating and fibrinolytic systems in children with the nephrotic syndrome].
    Kogan FV; Ananenko AA; Ignatova MS
    Pediatriia; 1984 Jun; (6):29-32. PubMed ID: 6566112
    [No Abstract]   [Full Text] [Related]  

  • 17. [Proteolytic systems and immune factors in hemophilia patients].
    Donskaia SD; Galkina SG
    Vrach Delo; 1988 Jul; (7):43-5. PubMed ID: 3055683
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of chromogenic substrates for estimation of indicators of kallikrein-kinin and blood coagulation systems in blood plasma of patients with nephrotic syndrome].
    Baskova IP; Paskhina TS; Poliantseva LR; Iakubovskaia RI; Tiero A
    Vopr Med Khim; 1983; 29(5):96-9. PubMed ID: 6557709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of a tripeptide chromogenic substrate for simultaneous determination of 4 indices of kallikrein-kinin system].
    Dotsenko VL; Iarovaia GA; Neshkova EA
    Vopr Med Khim; 1989; 35(2):128-33. PubMed ID: 2741408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma proteolysis and circulating cells in relation to varying endotoxin concentrations in porcine endotoxemia.
    Naess F; Roeise O; Pillgram-Larsen J; Ruud TE; Stadaas JO; Aasen AO
    Circ Shock; 1989 Jun; 28(2):89-100. PubMed ID: 2661049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.